Purinergic Signalling

Papers
(The TQCC of Purinergic Signalling is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Some reflections after a long life in science34
Neuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions27
Purinergic P2X7 receptor involves in anti-retinal photodamage effects of berberine27
Hippocampal astrocytes relieve anxiogenic behavior by increasing, via the release of ATP, excitatory synaptic transmission in dentate gyrus granule cells27
Electroacupuncture may alleviate diabetic neuropathic pain by inhibiting the microglia P2X4R and neuroinflammation26
Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas25
The impact of inosine on hippocampal synaptic transmission and plasticity involves the release of adenosine through equilibrative nucleoside transporters rather than the direct activation of adenosine23
Role of the P2X7 receptor in breast cancer progression21
The potential role of adenosinergic pathway and methylxanthines in Parkinson’s disease: Blowing in the wind or not20
P2Y12 receptor antagonism inhibits proliferation, migration and leads to autophagy of glioblastoma cells20
The P2X7 receptor/NLRP3 inflammasome signaling axis in sepsis: molecular mechanisms, organ-specific pathophysiology, and emerging therapeutic strategies19
The exploration of active components of 701 Dieda Zhentong patch and analgesic properties on chronic constriction injury rats17
Human plasmacytoid dendritic cells express the functional purinergic halo (CD39/CD73)17
Promoting glymphatic flow: A non-invasive strategy using 40 Hz light flickering16
Guanosine contributes to rapid purinergic regulation of dopamine during ischemia16
Moxibustion pre-treatment attenuates seizure severity during status epilepticus and counteracts the proconvulsant function of the purinergic P2X7 receptor15
P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways15
Astrocytic adenosine A2B receptors: a crucial player in brain function14
Macrophage P2Y6 receptor signalling as a key mediator and therapeutic target in atherosclerosis14
Brilliant blue G enhances cardiac function and suppresses ventricular arrhythmias by attenuating inflammation and fibrosis after post-myocardial infarction in rats14
ENTPD1 (CD39) and NT5E (CD73) expression in human medulloblastoma: an in silico analysis14
Correction to: A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes13
Pharmacological interaction and immune response of purinergic receptors in therapeutic modulation12
Identification of the promoter region of the human P2RX7 gene12
Diadenosine pentaphosphate regulates dendrite growth and number in cultured hippocampal neurons12
Effects of nanoflubendazole and purinergic signaling modulation in overcoming neuroblastoma chemoresistance12
Increased P2X7 level does not affect anxiety or stress-coping behavior in male mice12
Electroacupuncture may alleviate inflammatory pain by downregulating the expression of P2Y14 receptor in the primary somatosensory cortex11
The biphasic regulatory effect of adenosine A2B receptor in ischemic brain injury and its therapeutic potential10
Functional role of peripheral P2X3 receptor expression in trigeminal ganglion neurons: a microarray-based evaluation of the antagonist effect of P2X310
Pharmacological characterization of P2Y receptor subtypes – an update10
Editorial: purinergic signalling—perspectives from Australia and New Zealand10
P2Y14 receptor activation and neutrophil signaling: linking inflammation to systemic pathophysiology10
Purinergic P2X3 receptors in the carotid body as new therapeutic targets for controlling heart failure10
The P2Y2 receptor as a sensor of nucleotides and cell recruitment during inflammatory processes of the liver10
Pleiotropic effects of clopidogrel10
The P2X4-P2X7 purinergic axis in alcohol-related liver disease: from fibrogenesis to immunotherapy resistance9
Synthesis of new non-natural l-glycosidic flavonoid derivatives and their evaluation as inhibitors of Trypanosoma cruzi ecto-nucleoside triphosphate diphosphohydrolase 1 (TcNTPDase1)9
Extracellular ATP induces the proinflammatory phenotype transition of MH7A cells by activating P2X7 receptor9
P2 purinergic receptor dysregulation in urologic disease9
Preface to special issue “A tribute to Maria Teresa Miras-Portugal”9
Integrins α3 and α6 promote Th17 cell migration by activating the purinergic receptor P2X48
Cutaneous melanoma and purinergic modulation by phenolic compounds8
RETRACTED ARTICLE: Lysophosphatidylcholine induces adenosine release from macrophages via TRPM7-mediated mitochondrial activation8
Purinergic system in cancer stem cells8
Expression of the P2X1 receptor remains in the type II spiral ganglion neurons in the mature rat cochlea8
P2Y11/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?8
NPP1 and TNAP hydrolyze ATP synergistically during biomineralization8
Adenosine receptor signalling in Alzheimer’s disease7
P2Y6 promoted pruning of FSTL1 nerves by cutaneous macrophages to reset pain threshold and cardiac function7
P2Y6 receptor in the superior cervical ganglion: a key mediator of post-myocardial ischemic sympathetic hyperexcitability via NF-κB mediated neuroinflammation7
Ginsenosides enhance P2X7-dependent cytokine secretion from LPS-primed rodent macrophages7
Anti-inflammatory and analgesic properties of Polyphyllin VI revealed by network pharmacology and RNA sequencing7
Genetic polymorphisms of purinergic P2Y2 receptor were associated with the susceptibility to essential hypertension in Chinese postmenopausal women7
Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair7
Partners in health and disease: pineal gland and purinergic signalling7
The anti-inflammatory effect of physical exercise on type 2 diabetes: the role of purinergic signaling7
DUSP1/MKP-1 represents another piece in the P2X7R intracellular signaling puzzle in cerebellar cells: our last journey with Mª Teresa along the purinergic pathways of Eden7
P2Y11 receptor is a critical regulator of extracellular ATP-mediated premature senescence in lung fibroblasts: Implications of ER-Ca+2 release/mitochondrial ROS production signaling pathway7
Potential role of the P2X7 receptor in the proliferation of human diffused large B-cell lymphoma6
Correction to: The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia6
Role and recent progress of P2Y12 receptor in cancer development6
Identification of novel proteins involved in P2X7-mediated signaling cascades6
Heterologous expression and biochemical characterization of the recombinant nucleoside triphosphate diphosphohydrolase 2 (LbNTPDase2) from Leishmania (Viannia) braziliensis6
T cell-derived adenosine regulates fibroblast IL-6 formation via A2B receptors in the infarcted heart6
Fluorescent A2A and A3 adenosine receptor antagonists as flow cytometry probes6
Editorial—Translation of purinergic drugs into therapeutic use6
ATP and major affective disorders: the involvement of P2X receptors in pathophysiology6
Purinergic P2Y1 and P2Y12 receptors control enteric nervous system activity through neuro-glia-macrophage crosstalk6
Mixed circuit training as a non-pharmacological strategy to improve platelet function and oxidative balance in type 2 diabetes: role of purinergic signaling5
Correction to: Purinoceptor: a novel target for hypertension5
Purinergic signaling in liver disease: calcium signaling and induction of inflammation5
The enzymatic degradation of ATP to adenosine by microglial CD39 regulates neurovascular coupling and metabolic supply to the brain5
Molecular mechanisms of extracellular-ATP-mediated colorectal cancer progression: Implication of purinergic receptors-mediated nucleocytoplasmic shuttling of HuR5
Announcement of changes to the Editorial Board5
Antagonism of the ATP-gated P2X7 receptor inhibits the proliferation of hepatocellular carcinoma cells5
Retraction Note: Modulation of the TGF-β1-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells5
P2 purinergic receptor expression and function in tumor-related immune cells5
Phenolic compounds and chemotherapeutic agents differentially regulate P2X receptor subtypes in malignant melanoma5
EU COST Action CA21130 PRESTO ‘P2X receptors as therapeutic targets’ inaugural meeting report5
Light flickering with 40 Hz causes analgesia via activation of a retina-amygdala pathway and the local release of adenosine5
CD39 in the development and progression of pulmonary arterial hypertension5
In vivo phenotypic validation of adenosine receptor-dependent activity of non-adenosine drugs5
Gallic acid modulates purine metabolism and oxidative stress induced by ethanol exposure in zebrafish brain5
Host-directed therapeutic strategies against apicomplexan parasites: targeting purinergic P2 receptors5
Mechanosensitive release of ATP in the urinary bladder mucosa5
0.072324991226196